WO2008055254A3 - Preparations et procedes de liberation orale de proteines - Google Patents

Preparations et procedes de liberation orale de proteines Download PDF

Info

Publication number
WO2008055254A3
WO2008055254A3 PCT/US2007/083362 US2007083362W WO2008055254A3 WO 2008055254 A3 WO2008055254 A3 WO 2008055254A3 US 2007083362 W US2007083362 W US 2007083362W WO 2008055254 A3 WO2008055254 A3 WO 2008055254A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug
methods
subject
delivering
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/083362
Other languages
English (en)
Other versions
WO2008055254A2 (fr
Inventor
Daniel A Carr
Nicholas A Peppas
Mathilde C Boudes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
University of Texas at Austin
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of WO2008055254A2 publication Critical patent/WO2008055254A2/fr
Publication of WO2008055254A3 publication Critical patent/WO2008055254A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des compositions de libération de médicament, ainsi que des procédés associés de fabrication et d'utilisation de ces compositions. Certains modes de réalisation concernent une composition de libération de médicament, cette composition contenant une matrice d'hydrogel formée par un copolymère d'acide acrylique et une N-vinyl pyrrolidone, ladite matrice étant au moins partiellement réticulée, et un médicament placé à l'intérieur de la matrice d'hydrogel. L'invention concerne également des procédés de fabrication d'une composition de libération de médicament, ainsi que méthodes de traitement consistant à administrer ces compositions à un patient. Dans certains modes de réalisation, ces réseaux d'hydrogel peuvent être sensibles aux variations de pH, et notamment gonfler à un pH élevé pour libérer au moins une partie du médicament du réseau d'hydrogel.
PCT/US2007/083362 2006-11-01 2007-11-01 Preparations et procedes de liberation orale de proteines Ceased WO2008055254A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86384706P 2006-11-01 2006-11-01
US60/863,847 2006-11-01

Publications (2)

Publication Number Publication Date
WO2008055254A2 WO2008055254A2 (fr) 2008-05-08
WO2008055254A3 true WO2008055254A3 (fr) 2008-12-11

Family

ID=39345097

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/083362 Ceased WO2008055254A2 (fr) 2006-11-01 2007-11-01 Preparations et procedes de liberation orale de proteines

Country Status (1)

Country Link
WO (1) WO2008055254A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8183479B2 (en) 2009-05-01 2012-05-22 General Electric Company Lock mounting device
WO2011091307A1 (fr) * 2010-01-23 2011-07-28 University Of Connecticut Hydrogels à affinité, pour libération régulée de protéines
US10500256B2 (en) 2014-09-30 2019-12-10 Board Of Regents, The University Of Texas System Polymers for delivery of therapeutic proteins
US10265405B2 (en) 2014-11-18 2019-04-23 Board Of Regents, The University Of Texas System Polymers for delivery of factor VIII and/or factor IX
WO2016115234A1 (fr) * 2015-01-14 2016-07-21 Board Of Regents, The University Of Texas System Hydrogels pour l'administration de composés thérapeutiques

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177056A (en) * 1974-06-27 1979-12-04 Ciba-Geigy Corporation Water-insoluble hydrophilic copolymers used as carriers for medicaments and pesticides
US5573943A (en) * 1990-08-02 1996-11-12 Saramane Pty. Ltd. Cloning and expression of a rhoptry associated protein of P. falciparum

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177056A (en) * 1974-06-27 1979-12-04 Ciba-Geigy Corporation Water-insoluble hydrophilic copolymers used as carriers for medicaments and pesticides
US5573943A (en) * 1990-08-02 1996-11-12 Saramane Pty. Ltd. Cloning and expression of a rhoptry associated protein of P. falciparum

Also Published As

Publication number Publication date
WO2008055254A2 (fr) 2008-05-08

Similar Documents

Publication Publication Date Title
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
WO2010057036A3 (fr) Composition solide pour libération contrôlée d'agents actifs ionisables avec une faible solubilité aqueuse à ph bas, et procédés d'utilisation associés
WO2008039218A3 (fr) Inhibiteurs de la tyrosine kinase de bruton
WO2007048219A3 (fr) Composition medicamenteuse a liberation prolongee
TNSN08365A1 (en) Sustained release pharmaceutical composition on the basis of release system comprising an acid-soluble polymer and a ph-dependent polymer
HRP20070432B1 (hr) Gastrorezistentne farmaceutske formulacije koje sadrže rifamicin
EP2402323A3 (fr) Composes pour la suppression de mutations non-sens et procedes d'utilisation associes
WO2009109618A3 (fr) Nouveaux dérivés de 1-benzyl-3-hydroxyméthylindazole et leur utilisation dans le traitement des maladies basées sur l’expression de mcp-1, cx3cr1 et p40
WO2007002390A3 (fr) Compositions et procédés de modulation de l’épissage de smn2
WO2007100902A3 (fr) Conjugués de polymères contenant de l'acryloyloxyéthylphosphorylcholine et leur préparation
EP3895699A3 (fr) Compositions pharmaceutiques contenant de l'oxyhroxyde de fer
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2006039704A3 (fr) Composition pharmaceutique et methode de traitement d'une arthropathie a capsule articulaire
WO2008063768A3 (fr) Compositions et procédés pour traiter des maladies métaboliques
WO2005055948A3 (fr) Epha2, epha4 et lmw-ptp et procedes de traitement de maladies cellulaires hyperproliferatives
WO2007100555A3 (fr) Compositions contenant de la lactoferrine et leurs procédés d'utilisation pour favoriser la croissance de cellules cutanées
WO2008055254A3 (fr) Preparations et procedes de liberation orale de proteines
WO2003045319A3 (fr) Agents therapeutiques cibles et leurs utilisations
WO2005009287A3 (fr) Administration de medicament dans l'oreille interne et methodes d'utilisation correspondantes
UA99645C2 (ru) Гель, имеющий противовоспалительное и противоаллергическое действие
WO2007054976A3 (fr) Nouvelles compositions pharmaceutiques a liberation controlee a base de lipides
WO2008136034A3 (fr) Compositions ophtalmiques pour le traitement d'une hypertension oculaire et d'un glaucome
WO2007109648A3 (fr) Compositions et methodes de modulation d'entree calcique induite par reserve
WO2007134118A3 (fr) Composition à base de protéines et méthodes d'utilisation
WO2006133048A3 (fr) Compositions pharmaceutiques comprenant des agonistes des recepteurs prostanoides et procedes de fabrication et d'utilisation de celles-ci

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07868645

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07868645

Country of ref document: EP

Kind code of ref document: A2